Sigma-2 receptor (S2R) is a S2R ligand-binding site historically associated with reportedly 21.5 kDa proteins that have been linked to several diseases, such as cancer, Alzheimer's disease, and schizophrenia. The S2R is highly expressed in various tumors, where it correlates with the proliferative status of the malignant cells. Recently, S2R was reported to be the transmembrane protein TMEM97. Prior to that, we had been investigating the translocator protein (TSPO) as a potential 21.5 kDa S2R candidate protein with reported heme and sterol associations. Here, we investigate the contributions of TMEM97 and TSPO to S2R activity in MCF7 breast adenocarcinoma and MIA PaCa-2 (MP) pancreatic carcinoma cells. Additionally, the role of the reported...
AbstractSigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their e...
Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenou...
Abstract Background Resistance to modern adjuvant treatment is in part due to the failure of program...
AbstractThe sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal disease...
Breast cancer is the most common cancer in women among nearly every racial and ethnic group. About o...
The sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal diseases. Howev...
Sigma-2 receptors are intriguing targets under study for their involvement in tumors and neurodegene...
Shedding light on the controversial identity of the sigma-2 receptor with PGRMC1 M. L. Pati, C. A...
The sigma-2 receptor, whose gene remains to be cloned, has been validated as a biomarker for tumor c...
(1) Background: The structure of the Sigma 2 receptor/TMEM97 (σ2RTMEM97) has recently been reported....
The sigma-2 receptor (S2R) complex has been implicated in central nervous system disorders ranging f...
Multidrug resistance (MDR) is thought to be one of the main reasons for the failure of chemotherapy ...
The Translocator Protein (TSPO) is a high-affinity cholesterol-binding protein, located in the outer...
The sigma-2 receptor (S2R) complex has been implicated in central nervous system disorders ranging f...
Despite the interest aroused by sigma receptors (SRs) in the area of oncology, their role in tumor b...
AbstractSigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their e...
Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenou...
Abstract Background Resistance to modern adjuvant treatment is in part due to the failure of program...
AbstractThe sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal disease...
Breast cancer is the most common cancer in women among nearly every racial and ethnic group. About o...
The sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal diseases. Howev...
Sigma-2 receptors are intriguing targets under study for their involvement in tumors and neurodegene...
Shedding light on the controversial identity of the sigma-2 receptor with PGRMC1 M. L. Pati, C. A...
The sigma-2 receptor, whose gene remains to be cloned, has been validated as a biomarker for tumor c...
(1) Background: The structure of the Sigma 2 receptor/TMEM97 (σ2RTMEM97) has recently been reported....
The sigma-2 receptor (S2R) complex has been implicated in central nervous system disorders ranging f...
Multidrug resistance (MDR) is thought to be one of the main reasons for the failure of chemotherapy ...
The Translocator Protein (TSPO) is a high-affinity cholesterol-binding protein, located in the outer...
The sigma-2 receptor (S2R) complex has been implicated in central nervous system disorders ranging f...
Despite the interest aroused by sigma receptors (SRs) in the area of oncology, their role in tumor b...
AbstractSigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their e...
Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenou...
Abstract Background Resistance to modern adjuvant treatment is in part due to the failure of program...